URGN
Asset Logo

UROGEN PHARMA LTD

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-12.06%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

📈 Performance

Price History*

-17.55%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$11.45

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in URGN

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

20 weeks

💵 Average investment amount

$1,338

Last time a customer invested in URGN

251 days
URGN investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100%

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in URGN also invest in...

C4 Therapeutics, Inc

CCCC

📊 Share price

$4.05 USD
Find Out More

🙌 Performance (5Yr p.a)

-12.40%

📊 Share price

$3.28 USD

🙌 Performance (5Yr p.a)

37.32%

📊 Share price

$42.93 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-6.11%

📊 Share price

$2.23 USD

📊 Share price

$12.73 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

87.58%

📊 Share price

$820.55 USD

🙌 Performance (5Yr p.a)

24.80%

📊 Share price

$1.33 USD

📈 HIGH PRICE GROWTH

Compare
Add to watchlist